Both in Pharmaceuticals
Cellectar Biosciences INC NEW vs AEON Biopharma
Over the past year CLRB returned −62.5% and AEON returned −71.6%; their daily moves had a correlation of 0.06.
CLRB −62.5% AEON −71.6%Growth of $1, one year, split-adjusted
| Metric | CLRB | AEON |
|---|---|---|
| Price | $1.24 | $0.2640 |
| Market cap | $11.7M | $15.6M |
| Today | +2.48% | +6.32% |
| 1 month | −31.9% | +1.9% |
| 6 months | −51.6% | −72.3% |
| Year to date | −58.0% | −76.0% |
| 1 year | −65.5% | −71.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $34.0M | $743.0K |
| Dividend yield | — | — |
| Volatility (60d) | 66.3% | 114.4% |
| Short % of float | 2.9% | 28.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).